控制和治疗喘的差异:关注墨西哥裔美国儿童
Khamron Micheals1, Emily M Hall2, Sarah Chambliss2
1Department of Population Health, Dell Medical School, University of Texas, Austin, Tex; Steve Hicks School of Social Work, University of Texas, Austin, Tex.
The Journal of allergy and clinical immunology
|November 15, 2025
概括
与非西班牙裔白人儿童相比,墨西哥裔美国人和黑人儿童在喘控制和药物使用方面存在显著差异. 即使考虑到社会经济因素和医疗保健准入因素,这些差异仍然存在.
科学领域:
- 儿科肺病学 儿科肺病学
- 健康差距 研究 研究 研究 研究
- 流行病学 流行病学
背景情况:
- 在黑人和非西班牙裔白人儿童之间记录了喘发病率的差异.
- 墨西哥裔美国人和非西班牙裔白人儿童之间的喘控制差异知之甚少.
- 持续性喘影响了德克萨斯州中部的儿童.
研究的目的:
- 为了检查墨西哥裔美国人和非西班牙裔白人儿童之间的喘控制和治疗差异.
- 将这些差异与黑人和非西班牙裔白人儿童之间的差异进行比较.
- 将与社会经济地位和医疗保健获取相关的发现置于背景中.
主要方法:
- 利用了德克萨斯州家庭喘和肺部暴露评估研究的数据.
- 被调查的父母对控制良好的喘 (喘控制测试得分≥20),控制药物的使用,社会经济地位和医疗保健的准入情况进行了调查.
- 采用后勤回归模型来评估种族/种族和喘结果之间的关联,有或没有调整.
主要成果:
- 与非西班牙裔白人儿童相比,墨西哥裔美国儿童患喘的几率降低了81%,使用控制剂药物的几率降低了58%.
- 这些差异在调整社会经济和医疗保健准入因素后仍然存在.
- 与非西班牙裔白人儿童相比,黑人儿童的喘控制差异更为明显,控制剂药物使用的差异也相似.
结论:
- 墨西哥裔美国人和黑人儿童控制喘和使用控制药物的可能性明显低.
- 这些发现凸显了持续存在的喘差异,这些差异不能完全由社会经济地位或医疗保健获得来解释.
- 解决这些差异对于改善儿科喘结果至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


